Multiple Antigen Labeling - Vector Laboratories

More documents

Recommendations

Info

20Appendix 2: Quenching Endogenous Enzyme ActivityQuenching Endogenous Peroxidase ActivityMethod 1. 3% H 2 O 2 in water. Incubate for 5minutes. Rinse with water for 2-3 minutes. Thisis the most rapid and simplest technique forquenching, however the bubbling that mightoccur may damage the morphology of frozensections and specimens with large amounts ofendogenous enzyme activity (e.g., blood smears,etc.). This is a good general block.Method 2. 0.3% H 2 O 2 in methanol. Incubatefor 20-30 minutes. Rinse with water for 2-3minutes. This is the method of choice forfrozen sections and specimens with largeamounts of endogenous enzyme activity (bloodsmears, cytospins, etc.). The concentration ofH 2 O 2 can be doubled and/or incubation timeshortened as appropriate for the specimen.Methanol accelerates the destruction of theheme groups so a lower concentration of H 2 O 2can be used for a longer period of time. This isalso a good general block except for cell surfacemarkers.Method 3. 0.180 g β-D(+) glucose, 5 mg glucoseoxidase, 6.5 mg sodium azide in 50 ml PBS.Incubate sections for 1 hour at 37 ºC. Rinse inPBS 3 x 5 minutes. This reaction slowly andsteadily produces very low concentrations ofH 2 O 2 by enzymatic reaction. This method consistentlyand completely inhibits peroxidaseactivity.(Andrew S.M., Jasani, B.; Histochem J. 19, 426-430,1987.)Quenching Endogenous AlkalinePhosphatase ActivityMethod 1. If the endogenous activity is anisoenzyme other than the intestinal form, it canbe inhibited by the addition of levamisole (Cat.No. SP-5000) to the buffer used to prepare thesubstrate solution. Levamisole is a competitiveinhibitor of most alkaline phosphatase (AP)activity in tissues but is not bound by the isoformof AP used in detection systems.Intestinal alkaline phosphatase can be inhibitedby either of the following two methods:Method 2. Prior to staining, treat the sectionswith 20% acetic acid at 4 °C for 15 minutes.Method 3. Treat the sections with 2.3% periodicacid for 5 minutes and 0.02% potassium borohydridefor 2 minutes.(Bulman A.S. and Heyderman E.; J. Clin. Pathol. 34,1349-1351, 1981).Appendix 3: Buffer Recipes for Substrate SolutionsPBS (10 mM phosphate, 150 mM NaCI, pH 7.5)1.42 g Na 2 HPO 48.75 g NaCIto 950 ml distilled waterpH to 7.5 with phosphoric acid, bring up to finalvolume of 1 liter100 mM Tris-HCI, pH 8.2 or 9.512.11 g Tris Baseto 950 ml distilled waterpH to 8.2 or 9.5 with HCI, bring up to final volumeof 1 literNOTE: For 200 mM Tris-HCI, double the quantityof Tris Base.www.vectorlabs.com
C O N T A C T I N F O R M A T I O N(800) 227- 6666 (650) 697- 3600 Fax: (650) 697- 0339ADDRESS:30 Ingold RoadBurlingame, CA 94010TECHNICAL SERVICE:TEL: (650) 697-3600FAX: (650) 697-0339ORDERS:TEL: (800) 227-6666WEBSITE: http://www.vectorlabs.comEMAIL: vector@vectorlabs.comOutside USA: intl@vectorlabs.comFor technical questions or more detailed informationabout our products, please contact our technicalservice department.For the convenience of our customers in the U.K.and Canada, Vector Laboratories maintains acomplete inventory of all Vector products at oursubsidiaries:Vector Laboratories Ltd., 3 Accent Park,Bakewell Road, Orton Southgate,Peterborough, PE2 6XS, United Kingdomtel (01733) 237999, fax (01733) 237119email: vector@vectorlabs.co.ukVector Laboratories (Canada), Inc.3390 South Service RoadBurlington, Ontario, L7N 3J5, Canadatel (905) 681-0900, fax (905) 681-0166tel (888) 629-2121 (orders only)email: vectorca@netinc.caVector products are also available from over 35distributors worldwide. Please contact us or visitour website for a complete listing of theserepresentatives.Shown above: Tumor – Triple label• Ki67 (m), VECTASTAIN ® Universal Elite® ABC Kit, DAB HRP substrate (brown).• CD34 (m), VECTASTAIN ® Universal ABC-AP Kit, Vector ® Blue AP substrate (blue).• Multi-Cytokeratin (m), VECTASTAIN ® Universal ABC-AP Kit, Vector ® Red AP substrate (red).©Vector Laboratories, Inc. 2005
Page 1 and 2: DISCOVERYthrough color.A Guide to M
Page 3 and 4: 1Multiple Antigen Labeling in the S
Page 5 and 6: 3Peroxidase SubstratesIn general, p
Page 7 and 8: 5Order of Substrates in Labeling Pr
Page 9 and 10: 7Fig. 5Fig. 6Fig.7Add Second Primar
Page 11 and 12: 9General NotesControl SectionsContr
Page 13 and 14: 11Tonsil - Double label• CD3 (m),
Page 16 and 17: 14Immunofluorescence Staining Metho
Page 18 and 19: 16Multiple Immunofluorescent Labeli
Page 20 and 21: 18Skeletal Muscle (frozen, unfixed)

Multiple Antigen Labeling - Vector Laboratories

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?